Export 254 results:
Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is R  [Clear All Filters]
2021
A. G. Callahan, Coleman-Cowger, V. H., Schulkin, J., and Power, M. L., “Racial disparities in influenza immunization during pregnancy in the United States: A narrative review of the evidence for disparities and potential interventions.”, Vaccine, vol. 39, no. 35, pp. 4938-4948, 2021.
K. Page, Melia, M. T., Veenhuis, R. T., Winter, M., Rousseau, K. E., Massaccesi, G., Osburn, W. O., Forman, M., Thomas, E., Thornton, K., Wagner, K., Vassilev, V., Lin, L., Lum, P. J., Giudice, L. C., Stein, E., Asher, A., Chang, S., Gorman, R., Ghany, M. G., T Liang, J., Wierzbicki, M. R., Scarselli, E., Nicosia, A., Folgori, A., Capone, S., and Cox, A. L., “Randomized Trial of a Vaccine Regimen to Prevent Chronic HCV Infection.”, N Engl J Med, vol. 384, no. 6, pp. 541-549, 2021.
S. Whittier, Au, A., Sarraf, D., Oden, N., VanVeldhuisen, P., Scott, I., Ip, M., Watson, S., Blodi, B., and Domalpally, A., “Reproducibility of Grading Superficial vs Deep Retinal Hemorrhage in the Study of COmparative Treatments for REtinal Vein Occlusion 2 (SCORE2)”, in Association for Research in Vision and Ophthalmology Annual Meeting, 2021.
L. Revoredo, Salazar, D., Case, A., and Hart, B., “Responsible Tracking and Accounting of Participant Mental Health Urgency/Emergency Responses in Substance Use Treatment Clinical Trials”, in Society for Clinical Trials (SCT) Annual Conference, Virtual, 2021.
L. Revoredo, Salazar, D., Case, A., and Hart, B., “Responsible Tracking and Accounting of Participant Mental Health Urgency/Emergency Responses in Substance Use Treatment Clinical Trials”, in Society for Clinical Trials (SCT) Annual Conference, Virtual, 2021.
T. D. L. Keenan, Clemons, T. E., Domalpally, A., Elman, M. J., Havilio, M., Agrón, E., Benyamini, G., and Chew, E. Y., “Retinal Specialist versus Artificial Intelligence Detection of Retinal Fluid from OCT: Age-Related Eye Disease Study 2: 10-Year Follow-On Study.”, Ophthalmology, vol. 128, no. 1, pp. 100-109, 2021.
2020
J. Pidala, Hamadani, M., Dawson, P., Martens, M., Alousi, A. M., Jagasia, M., Efebera, Y. A., Chhabra, S., Pusic, I., Holtan, S. G., Ferrara, J. L. M., Levine, J. E., Mielcarek, M., Anasetti, C., Antin, J. H., Bolaños-Meade, J., Howard, A., Logan, B. R., Leifer, E. S., Pritchard, T. S., Horowitz, M. M., and MacMillan, M. L., “Randomized multicenter trial of sirolimus vs prednisone as initial therapy for standard-risk acute GVHD: the BMT CTN 1501 trial.”, Blood, vol. 135, no. 2, pp. 97-107, 2020.
C. R. Cohen, Wierzbicki, M. R., French, A. L., Morris, S., Newmann, S., Reno, H., Green, L., Miller, S., Powell, J., Parks, T., and Hemmerling, A., “Randomized Trial of Lactin-V to Prevent Recurrence of Bacterial Vaginosis.”, N Engl J Med, vol. 382, no. 20, pp. 1906-1915, 2020.
J. H. Beigel, Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., de Castilla, D. Lopez, Finberg, R. W., Dierberg, K., Tapson, V., Hsieh, L., Patterson, T. F., Paredes, R., Sweeney, D. A., Short, W. R., Touloumi, G., Lye, D. Chien, Ohmagari, N., Oh, M. - D., Ruiz-Palacios, G. M., Benfield, T., Fätkenheuer, G., Kortepeter, M. G., Atmar, R. L., C Creech, B., Lundgren, J., Babiker, A. G., Pett, S., Neaton, J. D., Burgess, T. H., Bonnett, T., Green, M., Makowski, M., Osinusi, A., Nayak, S., and H Lane, C., “Remdesivir for the Treatment of Covid-19 - Preliminary Report.”, N Engl J Med, 2020.
J. D. Klausner, Bristow, C. C., Soge, O. O., Shahkolahi, A., Waymer, T., Bolan, R. K., Philip, S. S., Asbel, L. E., Taylor, S. N., Mena, L. A., Goldstein, D. A., Powell, J. A., Wierzbicki, M. R., and Morris, S. R., “Resistance-Guided Treatment of Gonorrhea: A Prospective Clinical Study.”, Clin Infect Dis, 2020.
2019
H. Tillman, S Johnston, C., Farrant, M., Barsan, W., Elm, J. J., Kim, A. S., Lindblad, A. S., Palesch, Y. Y., and J Easton, D., “Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke: A Secondary Analysis of the POINT Randomized Clinical Trial.”, JAMA Neurol, vol. 76, no. 7, pp. 774-782, 2019.
2018
L. A. Jackson, Sahly, H. M. El, George, S., Winokur, P., Edwards, K., Brady, R. C., Rouphael, N., Keitel, W. A., Mulligan, M. J., Burton, R. L., Nakamura, A., Ferreria, J., and Nahm, M. H., “Randomized clinical trial of a single versus a double dose of 13-valent pneumococcal conjugate vaccine in adults 55 through 74 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine.”, Vaccine, vol. 36, no. 5, pp. 606-614, 2018.
J. P. Mulhall, Klein, E. A., Slawin, K., Henning, A. K., and Scardino, P. T., “A Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Utility of Tacrolimus (FK506) for the Prevention of Erectile Dysfunction Following Bilateral Nerve-Sparing Radical Prostatectomy.”, J Sex Med, vol. 15, no. 9, pp. 1293-1299, 2018.
G. Miller, Schaefer, H., Yoder, S., Miller, R., Winokur, P., Kotloff, K., Klassen, D., Wierzbicki, M., Amegashie, C., and Edwards, K., “A randomized, placebo-controlled phase I trial of live, attenuated herpes zoster vaccine in subjects with end-stage renal disease immunized prior to renal transplantation.”, Transpl Infect Dis, vol. 20, no. 3, p. e12874, 2018.
R. C. Brady, Jackson, L. A., Frey, S. E., Shane, A. L., Walter, E. B., Swamy, G. K., Schlaudecker, E. P., Szefer, E., Wolff, M., McNeal, M. Malone, Bernstein, D. I., and Steinhoff, M. C., “Randomized trial comparing the safety and antibody responses to live attenuated versus inactivated influenza vaccine when administered to breastfeeding women.”, Vaccine, vol. 36, no. 31, pp. 4663-4671, 2018.
C. E. Allen, Marsh, R., Dawson, P., Bollard, C. M., Shenoy, S., Roehrs, P., Hanna, R., Burroughs, L., Kean, L., Talano, J. - A., Schultz, K. R., Pai, S. - Y., K Baker, S., Andolina, J. R., Stenger, E. O., Connelly, J., Ramirez, A., Bryant, C., Eapen, M., and Pulsipher, M. A., “Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies.”, Blood, vol. 132, no. 13, pp. 1438-1451, 2018.
2017
J. M. Hare, DiFede, D. L., Rieger, A. C., Florea, V., Landin, A. M., El-Khorazaty, J., Khan, A., Mushtaq, M., Lowery, M. H., Byrnes, J. J., Hendel, R. C., Cohen, M. G., Alfonso, C. E., Valasaki, K., Pujol, M. V., Golpanian, S., Ghersin, E., Fishman, J. E., Pattany, P., Gomes, S. A., Delgado, C., Miki, R., Abuzeid, F., Vidro-Casiano, M., Premer, C., Medina, A., Porras, V., Hatzistergos, K. E., Anderson, E., Mendizabal, A., Mitrani, R., and Heldman, A. W., “Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM Trial.”, J Am Coll Cardiol, vol. 69, no. 5, pp. 526-537, 2017.
K. M. Gray, Sonne, S. C., McClure, E. A., Ghitza, U. E., Matthews, A. G., McRae-Clark, A. L., Carroll, K. M., Potter, J. S., Wiest, K., Mooney, L. J., Hasson, A., Walsh, S. L., Lofwall, M. R., Babalonis, S., Lindblad, R. W., Sparenborg, S., Wahle, A., King, J. S., Baker, N. L., Tomko, R. L., Haynes, L. F., Vandrey, R. G., and Levin, F. R., “A randomized placebo-controlled trial of N-acetylcysteine for cannabis use disorder in adults.”, Drug Alcohol Depend, vol. 177, pp. 249-257, 2017.
E. Shemesh, Mitchell, J., Neighbors, K., Feist, S., Hawkins, A., Brown, A., Wanrong, Y., Anand, R., Stuber, M. L., and Annunziato, R. A., “Recruiting a representative sample in adherence research-The MALT multisite prospective cohort study experience.”, Pediatr Transplant, vol. 21, no. 8, 2017.
T. L. Jensen, Frasketi, M., Conway, K., Villarroel, L., Hill, H., Krampis, K., and Goll, J. B., “RSEQREP: RNA-Seq Reports, an open-source cloud-enabled framework for reproducible RNA-Seq data processing, analysis, and result reporting.”, F1000Res, vol. 6, p. 2162, 2017.
2016
R. A. Wood, Kim, J. S., Lindblad, R., Nadeau, K., Henning, A. K., Dawson, P., Plaut, M., and Sampson, H. A., “A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy.”, J Allergy Clin Immunol, vol. 137, no. 4, pp. 1103-1110.e11, 2016.
G. G. Laport, Wu, J., Logan, B., Bachanova, V., Hosing, C., Fenske, T., Longo, W., Devine, S. M., Nademanee, A., Gersten, I., Horowitz, M., Lazarus, H. M., and Riches, M. L., “Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and High-Dose Rituximab for Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma: A Phase Two Multicenter Trial from the Blood and Marrow Transplant Clinical Trials Networ”, Biol Blood Marrow Transplant, vol. 22, no. 8, pp. 1440-1448, 2016.
K. Verdolini Abbott, Barton, F. Benedicty, Terhorst, L., and Shembel, A., “Retrospective Studies: A Fresh Look.”, Am J Speech Lang Pathol, vol. 25, no. 2, pp. 157-63, 2016.
2015
H. Wiley, Bailey, C., Cukras, C., Jaffe, G., Lee, R., Loken, E., Meyerle, C., Thompson, D., Wong, W., and Ferris, F., “A Randomized 36-Week Crossover Trial Comparing Ranibizumab and Bevacizumab for Diabetic Macular Edema”, in 2015 Annual Meeting of The Association for Research in Vision and Ophthalmology (ARVO), Denver, CO, 2015.
A. C Howard, Fernandez-Vina, M. A., Appelbaum, F. R., Confer, D. L., Devine, S. M., Horowitz, M. M., Mendizabal, A., Laport, G. G., Pasquini, M. C., and Spellman, S. R., “Recommendations for donor human leukocyte antigen assessment and matching for allogeneic stem cell transplantation: consensus opinion of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN).”, Biol Blood Marrow Transplant, vol. 21, no. 1, pp. 4-7, 2015.